View Cart  

Lawmakers, Watchdogs Turn Up Heat on FDA After Reports of Further Email Monitoring

A A
Lawmakers and watchdog groups are putting a brighter spotlight on the FDA, demanding the agency, HHS and White House take action to ensure whistleblower protections and investigate allegations of inappropriate email monitoring by the drug regulator.

To View This Article:

Login

Subscribe To Drug Industry Daily